WHO ICTRP trial
COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19)
EUCTR2020-001689-12-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-001689-12-GB |
|---|---|
| Public title | COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19) |
| Scientific title | COLCHICINE CORONAVIRUS SARS-CoV2 TRIAL - COLCORONA |
| Primary sponsor | Montreal Health Innovations Coordinating Centre |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Greece;Canada;Spain;Brazil;South Africa;United Kingdom |
| Conditions | COVID-19 MedDRA version: 23.0 Level: PT Classification code 10084268 Term: COVID-19 System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] |
| Interventions | Product Name: Colchicine Pharmaceutical Form: Coated tablet INN or Proposed INN: Colchicine CAS Number: 64-86-8 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 0.5- Pharmaceutical form of the placebo… |
| Registration date | Oct 15, 2020 |
| Target size | 6000 |
| Secondary IDs | MHIPS-2020-001;NCT04322682;2020-001689-12-ES |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: